Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof

The invention concerns pharmaceutical compositions containing as active principle a compound of formula (I) wherein: R1 represents a -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2R6 radical or one of its pharmaceutically acceptable salts. The invention also relates to derivates of formula (I), their pharmaceuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MYERS MICHAEL, FILOCHE BRUNO, BOUCHARD HERVE, BOUQUEREL JEAN, ACHARD DANIEL, HITTINGER AUGUSTIN, GRISONI SERGE
Format: Patent
Sprache:eng ; slo
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MYERS MICHAEL
FILOCHE BRUNO
BOUCHARD HERVE
BOUQUEREL JEAN
ACHARD DANIEL
HITTINGER AUGUSTIN
GRISONI SERGE
description The invention concerns pharmaceutical compositions containing as active principle a compound of formula (I) wherein: R1 represents a -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2R6 radical or one of its pharmaceutically acceptable salts. The invention also relates to derivates of formula (I), their pharmaceutically acceptable salts and their preparation. Opisujú sa farmaceutické kompozície obsahujúce ako účinnú látku aspoň jednu zlúčeninu všeobecného vzorca (I), v ktorom R1 znamená skupinu -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2-R6 alebo niektorú z ich farmaceuticky prijateľných solí. Opísané sú i deriváty zlúčeniny všeobecného vzorca (I), ich farmaceuticky prijateľné soli a spôsob ich prípravy.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SK287445BB6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SK287445BB6</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SK287445BB63</originalsourceid><addsrcrecordid>eNqNjr0KwkAQhNNYiPoO-wDaaPypI4pgI2gflsvELCZ7x92awqc3gqWF1TAfw8eMs8el4dixw9PEcUvOd8EnMfGahqLGoqJ34hdMKlFQhSg9m_RI89-YWCsKEYEjf0RkDSJ8Pc1GNbcJs29OMjoebvvTAsGXSGF4obDyel7utnm-LorN6o_JG1mEQwM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof</title><source>esp@cenet</source><creator>MYERS MICHAEL ; FILOCHE BRUNO ; BOUCHARD HERVE ; BOUQUEREL JEAN ; ACHARD DANIEL ; HITTINGER AUGUSTIN ; GRISONI SERGE</creator><creatorcontrib>MYERS MICHAEL ; FILOCHE BRUNO ; BOUCHARD HERVE ; BOUQUEREL JEAN ; ACHARD DANIEL ; HITTINGER AUGUSTIN ; GRISONI SERGE</creatorcontrib><description>The invention concerns pharmaceutical compositions containing as active principle a compound of formula (I) wherein: R1 represents a -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2R6 radical or one of its pharmaceutically acceptable salts. The invention also relates to derivates of formula (I), their pharmaceutically acceptable salts and their preparation. Opisujú sa farmaceutické kompozície obsahujúce ako účinnú látku aspoň jednu zlúčeninu všeobecného vzorca (I), v ktorom R1 znamená skupinu -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2-R6 alebo niektorú z ich farmaceuticky prijateľných solí. Opísané sú i deriváty zlúčeniny všeobecného vzorca (I), ich farmaceuticky prijateľné soli a spôsob ich prípravy.</description><language>eng ; slo</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=SK&amp;NR=287445B6$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101007&amp;DB=EPODOC&amp;CC=SK&amp;NR=287445B6$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MYERS MICHAEL</creatorcontrib><creatorcontrib>FILOCHE BRUNO</creatorcontrib><creatorcontrib>BOUCHARD HERVE</creatorcontrib><creatorcontrib>BOUQUEREL JEAN</creatorcontrib><creatorcontrib>ACHARD DANIEL</creatorcontrib><creatorcontrib>HITTINGER AUGUSTIN</creatorcontrib><creatorcontrib>GRISONI SERGE</creatorcontrib><title>Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof</title><description>The invention concerns pharmaceutical compositions containing as active principle a compound of formula (I) wherein: R1 represents a -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2R6 radical or one of its pharmaceutically acceptable salts. The invention also relates to derivates of formula (I), their pharmaceutically acceptable salts and their preparation. Opisujú sa farmaceutické kompozície obsahujúce ako účinnú látku aspoň jednu zlúčeninu všeobecného vzorca (I), v ktorom R1 znamená skupinu -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2-R6 alebo niektorú z ich farmaceuticky prijateľných solí. Opísané sú i deriváty zlúčeniny všeobecného vzorca (I), ich farmaceuticky prijateľné soli a spôsob ich prípravy.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjr0KwkAQhNNYiPoO-wDaaPypI4pgI2gflsvELCZ7x92awqc3gqWF1TAfw8eMs8el4dixw9PEcUvOd8EnMfGahqLGoqJ34hdMKlFQhSg9m_RI89-YWCsKEYEjf0RkDSJ8Pc1GNbcJs29OMjoebvvTAsGXSGF4obDyel7utnm-LorN6o_JG1mEQwM</recordid><startdate>20101007</startdate><enddate>20101007</enddate><creator>MYERS MICHAEL</creator><creator>FILOCHE BRUNO</creator><creator>BOUCHARD HERVE</creator><creator>BOUQUEREL JEAN</creator><creator>ACHARD DANIEL</creator><creator>HITTINGER AUGUSTIN</creator><creator>GRISONI SERGE</creator><scope>EVB</scope></search><sort><creationdate>20101007</creationdate><title>Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof</title><author>MYERS MICHAEL ; FILOCHE BRUNO ; BOUCHARD HERVE ; BOUQUEREL JEAN ; ACHARD DANIEL ; HITTINGER AUGUSTIN ; GRISONI SERGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SK287445BB63</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slo</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MYERS MICHAEL</creatorcontrib><creatorcontrib>FILOCHE BRUNO</creatorcontrib><creatorcontrib>BOUCHARD HERVE</creatorcontrib><creatorcontrib>BOUQUEREL JEAN</creatorcontrib><creatorcontrib>ACHARD DANIEL</creatorcontrib><creatorcontrib>HITTINGER AUGUSTIN</creatorcontrib><creatorcontrib>GRISONI SERGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MYERS MICHAEL</au><au>FILOCHE BRUNO</au><au>BOUCHARD HERVE</au><au>BOUQUEREL JEAN</au><au>ACHARD DANIEL</au><au>HITTINGER AUGUSTIN</au><au>GRISONI SERGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof</title><date>2010-10-07</date><risdate>2010</risdate><abstract>The invention concerns pharmaceutical compositions containing as active principle a compound of formula (I) wherein: R1 represents a -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2R6 radical or one of its pharmaceutically acceptable salts. The invention also relates to derivates of formula (I), their pharmaceutically acceptable salts and their preparation. Opisujú sa farmaceutické kompozície obsahujúce ako účinnú látku aspoň jednu zlúčeninu všeobecného vzorca (I), v ktorom R1 znamená skupinu -N(R4)R5, -N(R4)-CO-R5, -N(R4)-SO2-R6 alebo niektorú z ich farmaceuticky prijateľných solí. Opísané sú i deriváty zlúčeniny všeobecného vzorca (I), ich farmaceuticky prijateľné soli a spôsob ich prípravy.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slo
recordid cdi_epo_espacenet_SK287445BB6
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Pharmaceutical compositions containing azetidine derivatives, azetidine derivatives and preparation thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A33%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MYERS%20MICHAEL&rft.date=2010-10-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESK287445BB6%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true